Filter
1167
Text search:
HIV
expenditure
Featured
72
440
Language
Document type
823
174
57
54
27
9
8
5
4
3
1
1
Countries / Regions
74
71
48
41
40
38
37
36
35
34
34
31
30
27
25
22
22
22
21
20
18
16
15
13
12
12
11
10
10
9
8
7
7
7
6
6
6
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
713
59
31
25
23
3
3
Toolboxes
79
77
53
33
29
29
29
25
21
19
16
14
10
9
7
5
5
3
2
2
2
2
2
2
1
Reporting Period 2010-2011
The Republic of the Union of Myanmar’s National Strategic Plan on HIV/AIDS 2016–2020 is the strategic guide for the country’s response to HIV at national, state/regional and local levels. The
...
The National Strategic Plan for HIV/AIDS and STIs 2017-2024 spells out the objectives and targets that we have jointly committed to achieve. The plan describes the strategies and activities that will need to be implemented on the ground across India
...
R4D conducted a thorough desk review and qualitative fiscal space analysis, 19 interviews about financing for the three diseases and the extent of alignment between public financial management systems and health policy objectives, and a validation workshop with government officials.
Tanzania’ ...
Tanzania’ ...
Journal of the International AIDS Society, vol. 21 Issue no. 6 e 25142
Weaknesses in care programmes providing anti‐retroviral therapy (ART) persist and are often instigated by late HIV diagnosis and poor linkage to care. We investigated the ...
Weaknesses in care programmes providing anti‐retroviral therapy (ART) persist and are often instigated by late HIV diagnosis and poor linkage to care. We investigated the ...
Vol. 7, No. 1 (2018) | ISSN 2166-7403 (online) DOI 10.5195/cajgh.2018.295 | http://cajgh.pitt.edu
UNAIDS 2016 / Meeting Report
Experiences from Indonesia, Kenya, Uganda and Ukraine
Background: Comparable estimates of health spending are crucial for the assessment of health systems and to optimally deploy health resources. The methods used to track health spending continue to evolve, but little is known about the distribution of spending across diseases. We developed improved e
...
